v3.25.2
STOCK-BASED COMPENSATION
6 Months Ended
Jun. 30, 2025
Share-Based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION STOCK-BASED COMPENSATION
During each of the three and six months ended June 30, 2025 and 2024, we recognized $8 million, $13 million, $8 million and $14 million in stock-based compensation expense, respectively, which was allocated between cost of goods sold and selling, general and administrative expenses in the condensed consolidated statements of operations. We recognized tax benefits on stock-based compensation of $0 million, $1 million, $0 million, $1 million for the three and six months ended June 30, 2025 and 2024, respectively.
2025 Activity
Restricted Stock UnitsUnits
(in millions)
Weighted Average
Fair Value
Outstanding at January 1, 20251.0 $31.43 
Granted0.5 $34.37 
Vested(0.4)$30.69 
Forfeited(0.1)$31.84 
Outstanding at June 30, 20251.0 $33.13 
Tax expenses on the vesting of restricted stock units during the six months ended June 30, 2025 were immaterial.
At June 30, 2025, there was $20 million of unamortized expense relating to unvested restricted stock units that is expected to be amortized over a weighted average period of 1.5 years.
Performance Share UnitsUnits
(in millions)
Weighted Average
Fair Value
Outstanding at January 1, 20250.9 $35.84 
Granted0.3 $39.70 
Vested (1)
— $30.63 
Forfeited(0.2)$32.53 
Outstanding at June 30, 20251.0 $37.94 
(1)    Activity during the six months ended June 30, 2025 rounds to zero.
Our performance share units allow for participants to vest in zero to 200% of the target number of shares granted. At June 30, 2025, there was $22 million of unamortized expense relating to unvested performance share units that is expected to be amortized over a weighted average period of 1.9 years. The forfeitures include portions of performance share unit grants that were determined to not have vested during the period as a result of not meeting established financial performance thresholds.
Stock Options
The Black-Scholes option pricing model was used to estimate the fair values for options as of their grant date. There have been no options granted since 2019. There are currently 0.2 million options outstanding, all of which are vested and exercisable, with an average exercise price of $28.06, a weighted average contractual life of 2.6 years and an immaterial aggregate intrinsic value.
Cash received by the Company upon exercise of options during the three and six months ended June 30, 2025 was $1 million. There were immaterial tax benefits on these exercises.